Stockscreener 앱 받기
16.15
1.94%
-0.32
전일 마감가:
$16.47
열려 있는:
$16.64
하루 거래량:
28,741
Relative Volume:
0.77
시가총액:
$252.72M
수익:
$445.32M
순이익/손실:
$15.08M
주가수익비율:
61.04
EPS:
0.2646
순현금흐름:
$30.75M
1주 성능:
+0.94%
1개월 성능:
+24.71%
6개월 성능:
+4.67%
1년 성능:
-9.22%
1일 변동 폭
$16.15
$16.87
1주일 범위
$15.56
$16.87
52주 변동 폭
$10.80
$21.72
Natures Sunshine Products Inc Stock (NATR) Company Profile
명칭
Natures Sunshine Products Inc
전화
(801) 341-7900
주소
2901 WEST BLUEGRASS BLVD., LEHI
NATR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NATR
Natures Sunshine Products Inc
|
16.15 | 252.72M | 445.32M | 15.08M | 30.75M | 0.2646 |
|
KHC
Kraft Heinz Co
|
31.93 | 38.98B | 26.13B | 1.37B | 3.00B | 2.42 |
|
GIS
General Mills Inc
|
66.23 | 36.93B | 19.80B | 2.40B | 2.78B | 4.10 |
|
K
Kellanova Co
|
81.15 | 27.75B | 12.80B | 1.01B | 927.00M | 2.50 |
|
MKC
Mccormick Co Inc
|
77.79 | 21.04B | 6.68B | 792.60M | 774.40M | 2.40 |
|
HRL
Hormel Foods Corp
|
31.92 | 17.51B | 11.98B | 780.78M | 902.87M | 1.61 |
Natures Sunshine Products Inc Stock (NATR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-13 | 개시 | Canaccord Genuity | Buy |
| 2021-10-15 | 개시 | DA Davidson | Buy |
| 2015-04-09 | 개시 | Imperial Capital | In-line |
| 2014-06-02 | 개시 | Singular Research | Buy |
| 2013-03-08 | 재확인 | Imperial Capital | In-line |
Natures Sunshine Products Inc 주식(NATR)의 최신 뉴스
Estee Lauder Companies (EL-N) QuotePress Release - The Globe and Mail
The Honest Company (NASDAQ:HNST) Q3 Earnings: Leading The Personal Care Pack - Financial Content
Nu Skin Enterprises (NUS-N) QuotePress Release - The Globe and Mail
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
Personal Care Stocks Q3 Recap: Benchmarking Nature's Sunshine (NASDAQ:NATR) - Yahoo Finance
Emerging Small Caps to Explore in November 2024 - Simply Wall St
Nature's Sunshine Products stock target raised, holds buy on strong sales - Investing.com
Nature's Sunshine Appoints Steven Fasching to Board of Directors - The Manila Times
Nature’s Sunshine Appoints Steven Fasching to Board of Directors - GlobeNewswire
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Nature's Sunshine reports steady Q3 growth, raises 2024 outlook - Investing.com
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Call Highlights: Strong Asia Pacific ... By GuruFocus - Investing.com Canada
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Call Highl - GuruFocus.com
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Call Highlights: Strong Asia Pacific ... - Yahoo Finance
Nature's Sunshine: Q3 Earnings Snapshot - Houston Chronicle
Nature's Sunshine Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Nature's Sunshine (NASDAQ:NATR) Surprises With Strong Q3, Full-Year Sales Guidance Is Optimistic - Yahoo Finance
Nature's Sunshine Reports Third Quarter 2024 Results - The Manila Times
Herbalife Ltd (HLF-N) QuotePress Release - The Globe and Mail
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Report Pre - GuruFocus.com
Natures Sunshine Products Inc (NATR) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
Medifast Inc (MED-N) QuotePress Release - The Globe and Mail
Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For - Yahoo Finance
Nature's Sunshine Products (NATR) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Nature’s Sunshine Sets Third Quarter 2024 Conference Call for Thursday, November 7, 2024, at 5:00 p.m. ET - GlobeNewswire
Multivitamin Capsules Tablets Market May Set Epic Growth Story | Amway, Abbott, Pfizer, Bayer, ADM - openPR
Shanghai Fosun Pharmaceutical sells $29,946 in Natures Sunshine products stock - Investing.com UK
Nature's Sunshine Products: Cheap, But Not Entirely Without A Reason To Be (NATR) - Seeking Alpha
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
OTC Multivitamins And Minerals Supplements Market 2024 Segments Analysis by Top Key Players:Amway, Abbott, Bayer AG, Gla – IndiaPolitics.com - IndiaPolitics.com
Nature’s Sunshine Products (NASDAQ:NATR) Share Price Crosses Below 200 Day Moving Average – Time to Sell? - Defense World
Fosun pharmaceutical sells shares in Natures Sunshine Products for $145,188 - Investing.com India
Fosun Pharmaceutical Shanghai Sells 1,300 Shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR) Stock - MarketBeat
Nature's Sunshine Products (NASDAQ:NATR) Stock Price Crosses Below 200-Day Moving AverageHere's Why - MarketBeat
Herbal Weight Loss Products Industry Size, Share, Price, Trends, Forecast (2024-2034) - IndiaPolitics.com
Sonoma Pharmaceuticals (SNOA) Shares Surge Amid Positive Market Activity - GuruFocus.com
Diabetes Supplements Market By The 2031 | Nature’s Sunshine Forms, Caelus Health, Arkopharma Laboratories, Novo Nordisk, Herbalife International, Glucose Health, Inc – Times-BD24 - Times-BD24
Europe Herbal Weight Loss Products Industry Size, Share, Price, Trends, Forecast (2024-2034) - IndiaPolitics.com
Dietary Supplements Market Size Expected to Reach Nearly USD 474 Billion by 2032 - openPR
How To Trade (NATR) - Stock Traders Daily
Northwestern Mutual Wealth Management Co. Has $27.89 Million Stake in Goldman Sachs ActiveBeta International Equity ETF (NYSEARCA:GSIE) - Defense World
Bumble Inc. (NASDAQ:BMBL) Shares Sold by Dimensional Fund Advisors LP - Defense World
XTX Topco Ltd Acquires Shares of 11,923 Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
MBB Public Markets I LLC Increases Holdings in Stryker Co. (NYSE:SYK) - Defense World
American Century Companies Inc. Buys 53,221 Shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR) - MarketBeat
Natures Sunshine Products Inc (NATR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natures Sunshine Products Inc 주식 (NATR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 10 '24 |
Sale |
13.39 |
3,000 |
40,170 |
69,347 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 09 '24 |
Sale |
13.36 |
1,816 |
24,262 |
72,347 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 08 '24 |
Sale |
13.13 |
1,800 |
23,634 |
74,163 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 11 '24 |
Sale |
13.37 |
1,580 |
21,125 |
67,767 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 01 '24 |
Sale |
13.54 |
1,399 |
18,942 |
75,963 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 14 '24 |
Sale |
13.12 |
1,300 |
17,056 |
66,467 |
| Yates Bryant J | EVP & President, Europe |
Jun 06 '24 |
Sale |
15.30 |
3,068 |
46,940 |
98,852 |
| Norman Daniel C | EVP & President, Asia |
Nov 30 '23 |
Sale |
17.06 |
13,000 |
221,780 |
54,765 |
| Norman Daniel C | EVP & President, Asia |
Nov 29 '23 |
Sale |
17.59 |
2,000 |
35,180 |
67,765 |
0.16%
0.95%
자본화:
|
볼륨(24시간):